This is a preview of subscription content, log in via an institution to check access.
References
Bjorkman, P. J., Saper, M. A., Samroui, B., Bennet, W. S., Strominger, J. L., and Wiley, D. C.: Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329: 506–512, 1987
Buerstedde, J-M., Nilson, A. E., Chase, C. G., Bell, M. P., Beck, B. N., Pease, L. R., and Mckean, D. J.: A β polymorphic residues responsible for class II molecule recognition by alloreactive T cells. J Exp Med 169: 1645–1654, 1989
Hayashi, H., Ennis, P. D. H., Salter, R. D., Parham, P., Kano, K., and Takiguchi, M.: HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the α1 domain. J Immunol 142: 306–311, 1989
Hayashi, H., Ooba, T., Nakayama, S., Sekimata, M., Kano, K., and Takiguchi, M.: Allospecificities between HLA-Bw53 and HLA-B35 and HLA-B35 are generated by substitutions of the residues associated with HLA-Bw4/Bw6 public epitopes. Immunogenetics 32: 195–199, 1990
Heath, W. R., Hurd, M. E., Carbone, F. R., and Sherman, L. A.: Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature 341: 749–752, 1989
Hogan, K. T., Simojo, N., Walk, S. F., Engelhard, V. H., Maloy, W. L., Coligan, J. E., and Biddison, W. E.: Mutation in the α2 helix of HLA-A2 affect presentation but not inhibit binding of influenza virus matrix peptide. J Exp Med 168: 725–736, 1988
Hogan, K. T., Clayberger, C., Bernhard, E. J., Walk, S. T., Ridge, J. P., Parham, P., Krensky, A., and Engelhard, V. H.: A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2 specific antibodies and cytotoxic T lymphocytes. J Immunol 142: 2097–2104, 1989
López de Castro, J. A.: HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today 10: 239–246, 1989
Matsumoto, K., Yamamoto, J., Hiraiwa, M., Kano, K., and Takiguchi, M.: Discrimination of HLA-B5 cross reactive group antigens by human allogeneic CTL clones. Transplantation 49: 1164–1167, 1990
Ooba, T., Hayashi, H., Karaki, S., Tanabe, M., Kano, K., and Takiguchi, M.: The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 30: 76–80, 1989
Pierres, M., Marchetto, S., Naquet, P., Landais, D., Peccoud, J., Benoist, C., and Mathis, D.: I-Aα polymorphic residues that determine alloreactive T cell recognition. J Exp Med 169: 1655–1668, 1989
Santos-Aguade, J., Crimmis, M. A. V., Mentzer, S. J., Burakoff, S. T., and Strominger, J. L.: Alloreactivity studied with mutants of HLA-A2. Proc Natl Acad Sci USA 86: 8936–8940, 1989
Sekimata, M., Hiraiwa, M., Andrien, M., Dupont, E., Karaki, S., Yamamoto, J., Kano, K., and Takiguchi, M.: Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA. J Immunol 144: 3228–3233, 1990
Shimojo, N., Cowan, E. P., Engelhard, V. H., Maloy, W. L., Coligan, J. E., and Biddison, W. E.: A single amino acid substitution HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55–73. J Immunol 143: 558–564, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamamoto, J., Hiraiwa, M., Hayashi, H. et al. Two amino acid substitutions at residues 63 and 67 between HLA-B51 and HLA-Bw52 form multiple epitopes recognized by allogeneic T cells. Immunogenetics 33, 286–289 (1991). https://doi.org/10.1007/BF00230508
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00230508